ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, W. J.
Right arrow Articles by Norman, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, W. J.
Right arrow Articles by Norman, J. C.

The Annals of Thoracic Surgery, Vol 19, 540-551, Copyright © 1975 by The Society of Thoracic Surgeons


ARTICLES

An abdominal left ventricular assist device: preclinical studies

WJ Robinson, BS Benedict, DT Daly, DA Hughes, JJ Migliore, CW Hibbs, SR Igo and JC Norman

An abdominally positioned left ventricular assist device (ALVAD) has been evaluated in our most recent series of 25 calves weighing 99 plus or minus 12 kg. The ALVAD is a pneumatically actuated bladder pump, positioned subdiaphragmatically and connected between the left ventricular apex and the infrarenal abdominal aorta. The mean survival time in the calves was 41 days and the longest 65 days. The major effects of the pump are reduction of all indices of left ventricular work and increases in systemic perfusion. In the awake, unanesthetized calf, left ventricular pressure, dP/dt, and stroke work were decreased while peak aortic pressure, stroke volume, and cardiac output increased. These effects were corroborated at cardiac catheterization two to four weeks postoperatively; left ventriculograms also showed increases in ejection fraction. These data demonstrate the ALVAD's effectiveness in assuming left ventricular function and support over extended periods. The device has been developed for short-term postoperative clinical use in patients with reversible left ventricular failure.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. Scott-Burden, J. P. Bosley, D. Rosenstrauch, K. D. Henderson, F. J. Clubb Jr, H. C. Eichstaedt, K. Eya, I. Gregoric, T. J. Myers, B. Radovancevic, et al.
Use of autologous auricular chondrocytes for lining artificial surfaces: a feasibility study
Ann. Thorac. Surg., May 1, 2002; 73(5): 1528 - 1533.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
J. C. Norman, J. M. Duncan, O. H. Frazier, G. L. Hallman, D. A. Ott, G. J. Reul, and D. A. Cooley
Intracorporeal (Abdominal) Left Ventricular Assist Devices or Partial Artificial Hearts: A Five-Year Clinical Experience
Arch Surg, November 1, 1981; 116(11): 1441 - 1445.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1975 by The Society of Thoracic Surgeons.